EG ·
OMNICEF 300 MG 10 CAP
OMNICEF 300 MG 10 CAP
Composition
These source-reported data require scientific review and are not treatment advice.
LOPERAMIDE
· AMOUNT_PER_UNIT
CEFDINIR
· AMOUNT_PER_UNIT
Registration
Packages and prices
OMNICEF 300 MG 10 CAPSULES
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| DISSENTEN 2MG 15COMPRESSE | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| dinar 10 cap | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| LOPERASIN 2 GM 6CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MOTIJUST 2MG 10 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| LOPODIUM SYRUP- 30 ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| DINAR 125MG SUSP. 100ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| LOPERAZIN SYRUP-1ML5ML-30 ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| CEFDIN 125mg SUSP 60ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MAXIDINIR 250MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MAXIDINIR 125MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| EGYNIR 125 MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| IMODIUM 2 MG 6 CAP IMP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |